TScan Therapeutics, Inc. (TCRX)
0.2377
+0.03
(+12.87%)
USD |
NASDAQ |
Oct 15, 16:00
0.2377
0.00 (0.00%)
After-Hours: 20:00
TScan Therapeutics Profit Margin (Quarterly) : -2.89K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.89K% |
| March 31, 2026 | -2.92K% |
| December 31, 2025 | -895.1% |
| September 30, 2025 | -1.42K% |
| June 30, 2025 | -1.20K% |
| March 31, 2025 | -1.57K% |
| December 31, 2024 | -5.38K% |
| September 30, 2024 | -2.85K% |
| June 30, 2024 | -5.91K% |
| March 31, 2024 | -5.33K% |
| December 31, 2023 | -272.0% |
| Date | Value |
|---|---|
| September 30, 2023 | -591.6% |
| June 30, 2023 | -763.8% |
| March 31, 2023 | -331.7% |
| December 31, 2022 | -604.9% |
| September 30, 2022 | -483.1% |
| June 30, 2022 | -372.2% |
| March 31, 2022 | -534.8% |
| December 31, 2021 | -497.5% |
| September 30, 2021 | -656.7% |
| June 30, 2021 | -374.8% |
| March 31, 2021 | -390.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | -1.64% |
| Amgen, Inc. | 23.59% |
| Anika Therapeutics, Inc. | 10.15% |
| BioCryst Pharmaceuticals, Inc. | 35.92% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -96.52% |
| Return on Assets | -50.61% |
| Return on Invested Capital | -54.51% |
| Gross Profit Margin (Quarterly) | 33.49% |
| Operating Margin (Quarterly) | -2.90K% |
| Return on Net Operating Assets | -177.3% |